-+ 0.00%
-+ 0.00%
-+ 0.00%

Equifax (EFX) Stock Faces Margin Slippage As 10.7% Net Margin Tests Bullish Narratives

Simply Wall St·07/22/2026 21:28:36
語音播報

Equifax (EFX) has just put Q2 2026 on the board with revenue of US$1.7 billion and basic EPS of US$1.55, supported by trailing twelve month revenue of US$6.4 billion and EPS of US$5.73. Over recent quarters, the company has seen revenue move from US$1.54 billion in Q2 2025 to US$1.7 billion in Q2 2026, while basic EPS has ranged between US$1.07 and US$1.55 across that period. For investors, the key question is how these headline numbers relate to a slightly softer net margin profile and what that might indicate about the durability of Equifax’s earnings power.

See our full analysis for Equifax.

With the latest results on the table, the next step is to see how these numbers align with widely followed Equifax narratives around growth, risk, and profitability, and where those stories might need updating.

Curious how numbers become stories that shape markets? Explore Community Narratives

NYSE:EFX Revenue & Expenses Breakdown as at Jul 2026
NYSE:EFX Revenue & Expenses Breakdown as at Jul 2026

Net margin at 10.7% puts earnings quality in focus

  • Over the last 12 months Equifax converted US$6.4b in revenue into US$691.3 million in net income, which is a 10.7% net margin compared with 11% in the prior year.
  • What stands out for bullish investors is that this 10.7% margin sits alongside trailing basic EPS of US$5.73 and forecasts for roughly 18.45% annual earnings growth, which supports the view that Equifax is running a high quality earnings profile even as margin has eased slightly from 11%.
    • Supporters can point to the trailing twelve month move from US$5.16 to US$5.73 in basic EPS across the last five data points as evidence that earnings power has held up while margins stayed around the 11% mark.
    • Skeptics in that bullish camp still have to account for the step down in net margin from 11% to 10.7%, which indicates that recent profit growth is coming more from higher revenue, at US$6.4b over the last year, than from higher margins.

Bulls watching Equifax’s Q2 line up of US$6.4b in trailing revenue and a 10.7% net margin are likely to test whether that earnings engine can continue compounding or whether the margin slippage is an early warning sign for future reports 📊 Read the what the Community is saying about Equifax..

P/E of 29.8x versus 210.52 analyst target

  • Equifax trades on a trailing P/E of 29.8x against a current share price of US$170.45, compared with an analyst price target of US$210.52 and an industry average P/E of 21.8x.
  • Critics taking a bearish stance argue that paying 29.8x earnings for Equifax looks high relative to both industry and peer averages, and the Q2 numbers give them some backing because the net margin has slipped from 11% to 10.7% even as the share price still embeds a premium.
    • The stock’s P/E sits not only above the 21.8x industry average but also above the 26.9x peer average, so bears can say the valuation premium is clear while profitability has edged down, not up.
    • On the other hand, the same data set shows forecast earnings growth of about 18.45% per year, which challenges a strongly bearish view that the premium is entirely unjustified, because some investors may see that growth rate as at least partly explaining the higher multiple.

DCF fair value gap and 8.5% revenue growth forecasts

  • The provided DCF fair value of US$339.98 sits well above the current US$170.45 share price, while revenue is expected to grow around 8.5% per year and earnings roughly 18.45% per year.
  • Supporters of a more bullish narrative on Equifax point to this DCF fair value gap and the faster earnings growth forecast as evidence that the current price could be conservative, but the Q2 picture introduces tension because margins have eased to 10.7% and the company is flagged as carrying a high level of debt alongside recent insider selling.
    • The combination of a roughly US$169 difference between DCF fair value and the current price plus a 210.52 analyst target gives bulls valuation support, yet the softer margin compared with the prior 11% indicates profitability is not moving in the same direction as those valuation markers.
    • Recent insider selling and the reference to high debt levels mean that even if earnings grow at about 18.45% per year, investors still need to weigh balance sheet risk against that implied upside, rather than treating the DCF number as a simple green light.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Equifax's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Balanced or conflicted by Equifax’s mix of risks and rewards? The fastest way to cut through the noise is to review the underlying data yourself and pressure test both sides of the story using the 3 key rewards and 2 important warning signs.

See What Else Is Out There Beyond Equifax

Equifax combines a slightly softer 10.7% net margin, premium P/E multiples versus peers, high debt, and recent insider selling, which collectively raises questions about its risk profile.

If that mix of margin pressure, valuation premium, and balance sheet concerns feels uncomfortable, compare it with companies screened for stronger financial resilience using the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.